CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites

Nature Communications

June 28, 2019

10.1038/s41467-019-10735-7

Cited by 167

Related Papers

No related papers found

Powered by citation graph analysis